OPEN CLINICAL STUDY OF EYE-DROPS CONTAINING TETRAPEPTIDES DERIVED FROM SUBSTANCE P AND INSULIN-LIKE GROWTH FACTOR-1 FOR TREATMENT OF PERSISTENT EPITHELIAL DEFECTS ASSOCIATED WITH NEUROTROPHIC KERATOPATHY

Abstract

Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada Original study reprint requests: Dr Yamada N, Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube City, Yamaguchi 755-8505, Japan. E-mail address: [email protected].